ACYLIERTES OXYNTOMODULIN-PEPTID-ANALOG

European patent · EP3670529 · In force

Register entry

Publication number
EP3670529
Application number
EP18846196
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 16, 2018
Published
Jun 24, 2020
Granted
Jan 24, 2024
Protection ends at the latest
Aug 15, 2038
Next annual fee due
Aug 31, 2027
IPC classes
C07K 14/575 (2006.01)
A61K 38/00 (2006.01)
Priority
KR 20170103798 16.08.2017
PCT application
PCT/KR2018/009425 16.08.2018
PCT publication
WO2019/035672 21.02.2019
Filing language
Korean
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Dec 4, 2024

    Change

    Published in Swissreg on 04.12.2024

  4. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  5. Mar 22, 2024

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 22.03.2024

  6. Jan 24, 2024

    Granted

    Published in Swissreg on 24.01.2024

Parties

Inventor

RYU, Chae-Lim

Seongnam-si Gyeonggi-do 13499, KR

KIM, Tae-Hyoung

Seoul 07261, KR

LEE, Kyung-Seok

Yongin-si Gyeonggi-do 17079, KR

IM, Weon-Bin

Yongin-si Gyeonggi-do 16899, KR

YANG, Jae-Sung

Seoul 06624, KR

CHAE, Yu-Na

Yongin-si Gyeonggi-do 16807, KR

JUNG, Ill-Hun

Anyang-si Gyeonggi-do 13994, KR

BAEK, Gye-Rim

Yongin-si Gyeonggi-do 17083, KR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.